CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency

Open access

Abstract

OBJECTIVE: Renal insufficiency may increase the risk of hypoglycemia in hospitalized patients with diabetes who are treated with insulin. We randomized inpatients with type 2 diabetes and chronic renal failure to treatment with two different dose levels of insulin glargine and glulisine and studied control of hyperglycemia and the frequency of hypoglycemia. RESEARCH DESIGN AND METHODS: We conducted a multicenter, prospective, randomized trial to compare the efficacy of once-daily glargine and three-times daily glulisine at 0.5 vs. 0.25 units/kg/day. A total of 107 subjects had type 2 diabetes for >1 year, had a glomerular filtration rate <45 mL/min but did not require dialysis, and had an initial blood glucose (BG) >180 mg/dL. Doses were adjusted based on four-times daily BG measurements for 6 days. RESULTS: Mean BG on the first day was 196 ± 71 mg/dL in the group receiving 0.5 units/kg (0.5 group) and 197 ± 55 mg/dL in the group receiving 0.25 units/kg (0.25 group; P = 0.94). On days 2 to 6, mean BG was 174 ± 52 mg/dL in the 0.5 group and 174 ± 46 mg/dL in the 0.25 group (P = 0.96). There were no significant differences between groups in the percentage of BG values within the target range of 100 to 180 mg/dL on any of the 6 study days. In the 0.5 group, 30% experienced hypoglycemia (BG <70 mg/dL) compared with 15.8% of the 0.25 group (P = 0.08). CONCLUSIONS: Reduction of initial glargine/glulisine insulin weight-based dosing in hospitalized patients with diabetes and renal insufficiency reduced the frequency of hypoglycemia by 50% without compromising the control of hyperglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc12-0578

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Total daily insulin dose: 0.5 vs. 0.25 units/kg/day. Data are presented with the SD (error bars).
Figure 1 Total daily insulin dose: 0.5 vs. 0.25 units/kg/day. Data are presented with the SD (error bars).CC BY-NC-ND · PubMed Central
Figure 2 Mean daily blood glucose: 0.5 vs. 0.25 units/kg/day.
Figure 2 Mean daily blood glucose: 0.5 vs. 0.25 units/kg/day.CC BY-NC-ND · PubMed Central
Figure 3 Mean premeal and bedtime blood glucose: 0.5 vs. 0.25 units/kg/day.
Figure 3 Mean premeal and bedtime blood glucose: 0.5 vs. 0.25 units/kg/day.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 1

  1. Fadda, 1998, Metabolic and endocrine disturbances in uremia: glucose and insulin metabolism, 1390

Cited by

See all 104

Metadata

Authors
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M.
Affiliations
  • Rush University (US)
  • Division of Endocrinology, Loyola University, Maywood, Illinois
  • Loyola University Chicago (US)
  • Northwestern University (US)
Corresponding author
Baldwin, David
Venue
Diabetes Care
Published
2012-09-11
Volume
35
Issue
10
Pages
1970-1974
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2102487071
Cited by
103
References
26
Citations by year
2026: 4 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 11 · 2017: 8 · 2016: 14 · 2015: 16 · 2014: 10 · 2013: 8 · 2012: 4
FWCI
9.75
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
insulin glargine, insulin glulisine, type 2 diabetes, renal failure, hypoglycemia, hyperglycemia management, hospitalized patients, glomerular filtration rate, insulin dose adjustment
MeSH terms
Insulin Glargine, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Hospitalization, Humans, Hyperglycemia, Hypoglycemia, Insulin, Male, Middle Aged, Treatment Outcome, Insulin, Long-Acting, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency. https://app.cochat.ai/papers/10.2337/dc12-0578
The paper
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M. (2012). A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency. Diabetes Care. https://doi.org/10.2337/dc12-0578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.